Cerebrovascular Events Secondary to Pulmonary Arteriovenous Malformation Based on Genetic Heterogeneity

Overview

Journal Noro Psikiyatr Ars

Date 2017 Oct 17

PMID 29033646

Authors

Guner Celik

Huseyin Yurdakul

Erkan Yildirim

Affiliations

Soon will be listed here.

References

Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M . Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis. 2003; 14(3):261-8. DOI: 10.1097/01.mbc.0000061288.28953.c8. View

Kibe T, Mori Y, Okanishi T, Shimojima K, Yokochi K, Yamamoto T . Two concurrent chromosomal aberrations involving interstitial deletion in 1q24.2q25.2 and inverted duplication and deletion in 10q26 in a patient with stroke associated with antithrombin deficiency and a patent foramen ovale. Am J Med Genet A. 2011; 155A(1):215-20. DOI: 10.1002/ajmg.a.33786. View

Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K . Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology. 2000; 55(7):959-64. DOI: 10.1212/wnl.55.7.959. View

Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W . Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke. 2005; 36(7):1405-9. DOI: 10.1161/01.STR.0000170635.45745.b8. View

Bianca S, Cutuli N, Bianca M, Barrano B, Cataliotti A, Barone C . Clinical management of Rendu-Osler-Weber syndrome and genetic thrombophilia. Blood Coagul Fibrinolysis. 2010; 20(8):733. DOI: 10.1097/MBC.0b013e32832f42e8. View

Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M . Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003; 34(1):28-33. DOI: 10.1161/01.str.0000046457.54037.cc. View

Chaturvedi S . Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci. 1998; 160(2):158-60. DOI: 10.1016/s0022-510x(98)00243-3. View

Lichy C, Reuner K, Buggle F, Litfin F, Rickmann H, Kunze A . Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis. 2003; 16(1):83-7. DOI: 10.1159/000070120. View

Wechalekar A, Parapia L . Hereditary haemorrhagic telangiectasia with protein S deficiency in a family: a case report. Eur J Haematol. 2000; 64(1):59-60. DOI: 10.1034/j.1600-0609.2000.8l197.x. View

10.

Undas A, Bazan-Socha S, Swadzba J, Musial J . Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report. Blood Coagul Fibrinolysis. 2002; 13(1):53-6. DOI: 10.1097/00001721-200201000-00008. View

11.

Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi M . Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke. 2007; 38(7):2070-3. DOI: 10.1161/STROKEAHA.106.480863. View

12.

Ploos van Amstel H, Huisman M, Reitsma P, Wouter ten Cate J, Bertina R . Partial protein S gene deletion in a family with hereditary thrombophilia. Blood. 1989; 73(2):479-83. View

13.

Aznar J, Mira Y, Vaya A, Corella D, Ferrando F, Villa P . Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost. 2004; 91(5):1031-4. DOI: 10.1160/TH03-11-0690. View